Stryker CEO Kevin Lobo says he doesn't view the so-called 'repless' generic sales models piloted by orthopedic rivals Smith & Nephew and Wright Medical as a serious threat.
from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1zcV66D
Cap comentari:
Publica un comentari a l'entrada